LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Is traditional Chinese medicine useful in the treatment of COVID-19?

    Zhang, Kai

    The American journal of emergency medicine

    2020  Volume 38, Issue 10, Page(s) 2238

    MeSH term(s) COVID-19/therapy ; Drugs, Chinese Herbal/therapeutic use ; Humans ; Medicine, Chinese Traditional ; Pandemics ; SARS-CoV-2
    Chemical Substances Drugs, Chinese Herbal
    Keywords covid19
    Language English
    Publishing date 2020-03-25
    Publishing country United States
    Document type Letter
    ZDB-ID 605890-5
    ISSN 1532-8171 ; 0735-6757
    ISSN (online) 1532-8171
    ISSN 0735-6757
    DOI 10.1016/j.ajem.2020.03.046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Is traditional Chinese medicine useful in the treatment of COVID-19?

    Zhang, Kai

    The American Journal of Emergency Medicine ; ISSN 0735-6757

    2020  

    Keywords Emergency Medicine ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.ajem.2020.03.046
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection.

    Li, Hongtao / Sun, Meng / Lei, Fuzhi / Liu, Jinfeng / Chen, Xixiang / Li, Yaqi / Wang, Ying / Lu, Jiani / Yu, Danmei / Gao, Yueqiu / Xu, Jianrong / Chen, Hongzhuan / Li, Man / Yi, Zhigang / He, Xiao / Chen, Lili

    Antiviral research

    2024  Volume 224, Page(s) 105841

    Abstract: ... Traditional Chinese medicine (TCM) prescriptions have played an important role in the clinical treatment of patients with COVID ... 19 in China. However, it is difficult to uncover the potential molecular mechanisms ... The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome ...

    Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been ongoing for more than three years and urgently needs to be addressed. Traditional Chinese medicine (TCM) prescriptions have played an important role in the clinical treatment of patients with COVID-19 in China. However, it is difficult to uncover the potential molecular mechanisms of the active ingredients in these TCM prescriptions. In this paper, we developed a new approach by integrating the experimental assay, virtual screening, and the experimental verification, exploring the rapid discovery of active ingredients from TCM prescriptions. To achieve this goal, 4 TCM prescriptions in clinical use for different indications were selected to find the antiviral active ingredients in TCMs. The 3-chymotrypsin-like protease (3CL
    MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2 ; Rosmarinic Acid ; Peptide Hydrolases ; Antiviral Agents/pharmacology ; Protease Inhibitors/pharmacology ; Molecular Docking Simulation
    Chemical Substances Rosmarinic Acid (MQE6XG29YI) ; Peptide Hydrolases (EC 3.4.-) ; Antiviral Agents ; Protease Inhibitors
    Language English
    Publishing date 2024-02-24
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 306628-9
    ISSN 1872-9096 ; 0166-3542
    ISSN (online) 1872-9096
    ISSN 0166-3542
    DOI 10.1016/j.antiviral.2024.105841
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Xuanfei Baidu Decoction regulates NETs formation via CXCL2/CXCR2 signaling pathway that is involved in acute lung injury.

    Zhou, Mengen / Liu, Yiman / Qin, Honglin / Shang, Ting / Xue, Zhifeng / Yang, Shuang / Zhang, Han / Yang, Jian

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2023  Volume 161, Page(s) 114530

    Abstract: ... first-line traditional Chinese medicine (TCM) formula therapeutic strategy for COVID-19 patients. Prior ... symptoms in Coronavirus Disease 2019 (COVID-19) patients. Xuanfei Baidu Decoction (XFBD) is a recommend ... behind it was also firstly explained, that is XFBD regulated NETs formation via CXCL2/CXCR2 axis ...

    Abstract Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening symptoms in Coronavirus Disease 2019 (COVID-19) patients. Xuanfei Baidu Decoction (XFBD) is a recommend first-line traditional Chinese medicine (TCM) formula therapeutic strategy for COVID-19 patients. Prior studies demonstrated the pharmacological roles and mechanisms of XFBD and its derived effective components against inflammation and infections through multiple model systems, which provided the biological explanations for its clinical use. Our previous work revealed that XFBD inhibited macrophages and neutrophils infiltration via PD-1/IL17A signaling pathway. However, the subsequent biological processes are not well elucidated. Here, we proposed a hypothesis that XFBD can regulate the neutrophils-mediated immune responses, including neutrophil extracellular traps (NETs) formation and the generation of platelet-neutrophil aggregates (PNAs) after XFBD administration in lipopolysaccharide (LPS)-induced ALI mice. The mechanism behind it was also firstly explained, that is XFBD regulated NETs formation via CXCL2/CXCR2 axis. Altogether, our findings demonstrated the sequential immune responses of XFBD after inhibiting neutrophils infiltration, as well as shedding light on exploiting the therapy of XFBD targeting neutrophils to ameliorate ALI during the clinical course.
    MeSH term(s) Animals ; Mice ; Extracellular Traps ; COVID-19/metabolism ; Acute Lung Injury/metabolism ; Neutrophils ; Signal Transduction
    Chemical Substances xuanfei baidu
    Language English
    Publishing date 2023-03-16
    Publishing country France
    Document type Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2023.114530
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau.

    Xu, Cong / Wang, Jue / Yu, Lili / Sui, Xinbing / Wu, Qibiao

    Frontiers in public health

    2023  Volume 10, Page(s) 1029171

    Abstract: ... traditional Chinese medicine treatment, etc.: Discussion: In Macau, compared with the previous subvariants, BA.5 is ... become the dominant strain of the SARS-CoV-2 virus and led to escalating COVID-19 cases, how to cope ... of the previous variants of COVID-19 in Macau. The symptomatic cases accounted for 38.71% of the total cases ...

    Abstract Introduction: Due to its high transmissibility and immune escape, Omicron subvariant BA.5 has become the dominant strain of the SARS-CoV-2 virus and led to escalating COVID-19 cases, how to cope with it becomes an urgent issue. A BA.5 infection surge burst out on 18 June 2022 and brought an unprecedented challenge to Macau, the most densely populated region worldwide. This study aimed to analyze the characteristics of this outbreak and summarize the useful anti-epidemic measures and experiences during this outbreak.
    Methods: All data were obtained from the Government Portal of Macao SAR (https://www.gov.mo), and the Special Webpage Against Epidemics, the Macao Health Bureau (www.ssm.gov.mo). An epidemiologic study was performed to analyze epidemic outcomes, including the infection rate, the proportion of symptomatic cases, the case fatality ratio (CFR), etc. Data were analyzed using SPSS Version 20. A
    Results: The BA.5 outbreak resulted in 1,821 new cases, which was significantly more than the cumulative cases of the previous variants of COVID-19 in Macau. The symptomatic cases accounted for 38.71% of the total cases, which was higher than that of the previous variants. After 6-week concerted efforts, Macau effectively controlled the outbreak, with an infection rate of 0.27%, which was much lower than many BA.5-attacked regions. The CFR was approximately 0.86%, which was not statistically different from that of previous variants. Six victims were chronically ill senior elders and their vaccination rate was much lower than the average level. Macau took a comprehensive anti-epidemic strategy to win a quick victory against BA.5, especially the "relatively static" strategy that was first formulated and applied by Macau for the management of the COVID-19 pandemic. Successful experience showed that although BA.5 was highly contagious, it could be contained by comprehensive anti-epidemic measures, including adequate anti-epidemic preparation, herd immunity through vaccination, repeated mass nucleic acid tests and rapid antigen tests, KN-95 mask mandate, the "relatively static" strategy, precise prevention and control, epidemiological investigation and tracing, and traditional Chinese medicine treatment, etc.
    Discussion: In Macau, compared with the previous subvariants, BA.5 is associated with increased transmissibility and a higher proportion of symptomatic cases, however, the risk of death remains similar, and the infection rate is much lower than that in many other BA.5-attacked regions. BA.5 is highly contagious but still containable, Macau's experience may offer hints for the regions experiencing the BA.5 waves to choose or adjust a more rational anti-epidemic strategy.
    MeSH term(s) Humans ; Aged ; Macau/epidemiology ; Pandemics ; COVID-19/epidemiology ; SARS-CoV-2 ; Disease Outbreaks
    Language English
    Publishing date 2023-01-10
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2711781-9
    ISSN 2296-2565 ; 2296-2565
    ISSN (online) 2296-2565
    ISSN 2296-2565
    DOI 10.3389/fpubh.2022.1029171
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: "The History of Chinese Medicine Really Is Very Detailed Regarding Pandemics": A Qualitative Analysis of Evidence-Based Practice and the Use of Chinese Herbal Medicine by Licensed Acupuncturists During the COVID-19 Pandemic in the United States.

    Anderson, Belinda J / Zappa, Melissa / Glickstein, Barbara / Taylor-Swanson, Lisa

    Journal of integrative and complementary medicine

    2023  Volume 29, Issue 11, Page(s) 738–746

    Abstract: Objective: ...

    Abstract Objective:
    MeSH term(s) Humans ; United States/epidemiology ; COVID-19/epidemiology ; COVID-19/therapy ; Drugs, Chinese Herbal/therapeutic use ; Medicine, Chinese Traditional ; Pandemics ; Evidence-Based Practice
    Chemical Substances Drugs, Chinese Herbal
    Language English
    Publishing date 2023-06-12
    Publishing country United States
    Document type Journal Article
    ISSN 2768-3613
    ISSN (online) 2768-3613
    DOI 10.1089/jicm.2023.0033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Chinese Medicine, Which Targets Body's Response State, Is An Effective Way to Treat Epidemic Infectious Diseases.

    Yuan, Bing

    Chinese journal of integrative medicine

    2020  Volume 28, Issue 2, Page(s) 168–175

    Abstract: ... of directly killing or inactivating pathogens, which are used in modern medicine, CM is an effective treatment ... a treatment method consistent with the personalized concept of precision medicine. Compared with the methods ... methods and the organic combination of both treatment methods of modern medicine and CM will provide ...

    Abstract In the fight against epidemic infectious diseases in the past 2,000 years, Chinese medicine (CM) has gradually developed a complete response system including diagnosis and treatment. The focal point of CM in the treatment of infectious diseases is the personalized response state to pathogen, which is a treatment method consistent with the personalized concept of precision medicine. Compared with the methods of directly killing or inactivating pathogens, which are used in modern medicine, CM is an effective treatment modality that has a wider range of points of action in the human body. The remarkable effects achieved while treating SARS in 2003 and the current coronavirus disease 2019 (COVID-19) pneumonia and the history of the effective responses to epidemics in the past 2,000 years have fully demonstrated the effectiveness of CM in treating infectious diseases. This article discusses the different treatment mechanisms for infectious diseases in CM and modern medicine and the advantages of CM methods, which will reacquaint the world with CM. The improvement of the diagnosis and treatment system of CM based on scientific concepts and methods and the organic combination of both treatment methods of modern medicine and CM will provide the best solution for humans to defeat epidemic infectious diseases.
    MeSH term(s) COVID-19 ; Communicable Diseases/epidemiology ; Communicable Diseases/therapy ; Drugs, Chinese Herbal ; Epidemics ; Humans ; Medicine, Chinese Traditional ; SARS-CoV-2
    Chemical Substances Drugs, Chinese Herbal
    Keywords covid19
    Language English
    Publishing date 2020-10-10
    Publishing country China
    Document type Journal Article
    ZDB-ID 2171254-2
    ISSN 1993-0402 ; 1672-0415
    ISSN (online) 1993-0402
    ISSN 1672-0415
    DOI 10.1007/s11655-020-3324-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: What Is the Role of Pharmacists in Treating COVID-19 Patients? The Experiences and Expectations of Front Line Medical Staff

    Xuedong Jia / Wan Zhang / Shuzhang Du / Linlin Wen / Hongye Li / Zhao Yin / Jun Li / Xiaojian Zhang

    Frontiers in Public Health, Vol

    2021  Volume 9

    Abstract: ... stocked drugs, including traditional Chinese medicine preventative preparations, providing drug ... the professional expectations of medical staff for pharmacists in treating COVID-19 patients from the perspectives ... with frontline medical staff working in isolation wards during COVID-19. The interview data were analyzed, and ...

    Abstract Aims: The study aimed to understand the role and the core values of pharmacists and the professional expectations of medical staff for pharmacists in treating COVID-19 patients from the perspectives of the frontline medical staff. The findings help to understand and provide a reference for the career growth path of future pharmacists.Methods: A phenomenological method was used to conduct in-depth interviews with frontline medical staff working in isolation wards during COVID-19. The interview data were analyzed, and the themes were extracted.Results: Pharmacists played a positive role in ensuring the supply of non-routinely stocked drugs, including traditional Chinese medicine preventative preparations, providing drug information and medication consultation for complex patients, and identifying adverse drug reactions. However, at present, the integration of pharmacists and nurses is poor with inadequate communication, and the pharmaceutical care activities provided to physicians were still not comprehensive.Conclusions: The level of pharmaceutical care provided by pharmacists needs to be further strengthened. Frontline medical teams generally have high professional expectations for pharmacists, including expecting pharmacists to become drug therapy experts. They expect pharmacists to fully participate in clinical decision-making, especially playing a central role in managing drug interactions, contraindications, and other clinical uses of drugs.
    Keywords COVID-19 ; pharmacists ; play a role ; medical staff ; qualitative research ; Public aspects of medicine ; RA1-1270
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.

    Xia, Qi-Dong / Xun, Yang / Lu, Jun-Lin / Lu, Yu-Chao / Yang, Yuan-Yuan / Zhou, Peng / Hu, Jia / Li, Cong / Wang, Shao-Gang

    Cell proliferation

    2020  Volume 53, Issue 12, Page(s) e12949

    Abstract: ... 19-related gene set was established using the Traditional Chinese Medicine Systems Pharmacology ... capsule (LQC) has shown therapeutic effects in patients with COVID-19. This study is aimed to discover ... Objectives: Coronavirus disease 2019 (COVID-19) is rapidly spreading worldwide. Lianhua Qingwen ...

    Abstract Objectives: Coronavirus disease 2019 (COVID-19) is rapidly spreading worldwide. Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID-19. This study is aimed to discover its molecular mechanism and provide potential drug targets.
    Materials and methods: An LQC target and COVID-19-related gene set was established using the Traditional Chinese Medicine Systems Pharmacology database and seven disease-gene databases. Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis and protein-protein interaction (PPI) network were performed to discover the potential mechanism. Molecular docking was performed to visualize the patterns of interactions between the effective molecule and targeted protein.
    Results: A gene set of 65 genes was generated. We then constructed a compound-target network that contained 234 nodes of active compounds and 916 edges of compound-target pairs. The GO and KEGG indicated that LQC can act by regulating immune response, apoptosis and virus infection. PPI network and subnetworks identified nine hub genes. The molecular docking was conducted on the most significant gene Akt1, which is involved in lung injury, lung fibrogenesis and virus infection. Six active compounds of LQC can enter the active pocket of Akt1, namely beta-carotene, kaempferol, luteolin, naringenin, quercetin and wogonin, thereby exerting potential therapeutic effects in COVID-19.
    Conclusions: The network pharmacological strategy integrates molecular docking to unravel the molecular mechanism of LQC. Akt1 is a promising drug target to reduce tissue damage and help eliminate virus infection.
    MeSH term(s) Apoptosis/drug effects ; COVID-19/prevention & control ; Drugs, Chinese Herbal/pharmacology ; Gene Ontology ; Humans ; Molecular Docking Simulation/methods ; Protein Interaction Maps/drug effects ; Proto-Oncogene Proteins c-akt/drug effects ; Proto-Oncogene Proteins c-akt/metabolism ; SARS-CoV-2/drug effects ; SARS-CoV-2/pathogenicity
    Chemical Substances Drugs, Chinese Herbal ; AKT1 protein, human (EC 2.7.11.1) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1)
    Keywords covid19
    Language English
    Publishing date 2020-11-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 1064202-x
    ISSN 1365-2184 ; 0008-8730 ; 0960-7722
    ISSN (online) 1365-2184
    ISSN 0008-8730 ; 0960-7722
    DOI 10.1111/cpr.12949
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top